Cargando…

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients

BACKGROUND: Soft tissue sarcomas (STSs) are rare tumors and occur at any site in the body. Our goal was to identify a putative molecular mechanism for N6-methyladenosine (m6A) lncRNA alteration and to develop predictive biomarkers for sarcoma. METHODS: The lncRNA levels were obtained from TCGA datas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaohe, Li, Hongbo, Zhou, Liuzhi, Wu, Di, Zhou, Shixiang, Yang, Yao, Hu, Yabin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166981/ https://www.ncbi.nlm.nih.gov/pubmed/35669241 http://dx.doi.org/10.1155/2022/1093805

Ejemplares similares

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer
por: Yuan, Congfei, et al.
Publicado: (2022)

Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling
por: Yin, Lu, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

Novel insights into mutual regulation between N(6)-methyladenosine modification and LncRNAs in tumors
por: Zhang, Nan, et al.
Publicado: (2023)

N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
por: Zhang, He, et al.
Publicado: (2022)

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients
por: Wu, Wei Jun, et al.
Publicado: (2023)

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients
por: Xu, Shuyu, et al.
Publicado: (2022)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
por: Chu, Binxiang, et al.
Publicado: (2022)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
por: Song, Danjun, et al.
Publicado: (2023)

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
por: Huang, Xin, et al.
Publicado: (2022)

Comprehensive analysis of differences of N(6)-methyladenosine of lncRNAs between atrazine-induced and normal Xenopus laevis testis
por: Qi, Xuejie, et al.
Publicado: (2021)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

N6-Methyladenosine (m(6)A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
por: Zhou, Yang, et al.
Publicado: (2022)

Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis
por: Gao, Chen, et al.
Publicado: (2022)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
por: Min, Li, et al.
Publicado: (2017)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

Identification and validation of N6-methyladenosine (m6A)-related lncRNAs signature for predicting the prognosis of laryngeal carcinoma, especially for smoking patients
por: Chen, Yuqing, et al.
Publicado: (2023)

Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer
por: Zhong, Xiaoxiao, et al.
Publicado: (2021)

Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
por: Zhang, Pei, et al.
Publicado: (2021)

LncRNAs: Novel Biomarkers for Pancreatic Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
por: Gao, Chen, et al.
Publicado: (2022)

N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer
por: Zhang, Hongliang, et al.
Publicado: (2021)

Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)

The role of M(6)A modification in the regulation of tumor-related lncRNAs
por: Lan, Yufei, et al.
Publicado: (2021)

N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer
por: Shi, Rui, et al.
Publicado: (2021)

LncRNAs Expression in Preeclampsia Placenta Reveals the Potential Role of LncRNAs Contributing to Preeclampsia Pathogenesis
por: He, Xiaoju, et al.
Publicado: (2013)

LncRNAs regulate metabolism in cancer
por: Lin, Wenyu, et al.
Publicado: (2020)

Identification of lncRNAs by microarray analysis reveals the potential role of lncRNAs in cervical cancer pathogenesis
por: Huang, Jiaming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h3c11jfhov2rg481mqkbauun1h